Macular Degeneration

Contributing journals to this collection:
JAMA & Archives Journals

Citations 121-130 of 299 total displayed.

Past content

Special Articles
Macular Pigment: A Review of Current Knowledge

A. Jeffrey Whitehead; Julie A. Mares; Ronald P. Danis
Arch Ophthalmol 2006; 124: 1038-1045. [Abstract] [Full text] [PDF]  

Clinical Sciences
Lesion Morphology in Age-Related Macular Degeneration and Its Therapeutic Significance

Paul E. Beaumont; H. Kwon Kang
Arch Ophthalmol 2006; 124: 807-812. [Abstract] [Full text] [PDF]  

Clinical Crossroads
A 76-Year-Old Man With Macular Degeneration

Jorge G. Arroyo
JAMA 2006; 295: 2394-2406. [Extract] [Full text] [PDF]  

JAMA Patient Page
Age-Related Macular Degeneration

Sharon Parmet; Cassio Lynm; Richard M. Glass
JAMA 2006; 295: 2438. [Extract] [Full text] [PDF] [ Spanish PDF ]  

Clinical Sciences
Occult With No Classic Subfoveal Choroidal Neovascular Lesions in Age-Related Macular Degeneration: Clinically Relevant Natural History Information in Larger Lesions With Good Vision From the Verteporfin in Photodynamic Therapy (VIP) Trial: VIP Report No. 4

Writing Committee for the VIP Study Group
Arch Ophthalmol 2006; 124: 660-664. [Abstract] [Full text] [PDF]  

Epidemiology
Prevalence of Age-Related Maculopathy in Older Europeans: The European Eye Study (EUREYE)

Cristina A. Augood; Johannes R. Vingerling; Paulus T. V. M. de Jong; Usha Chakravarthy; Johan Seland; Gisele Soubrane; Laura Tomazzoli; Fotis Topouzis; Graham Bentham; Mati Rahu; Jesus Vioque; Ian S. Young; Astrid E. Fletcher
Arch Ophthalmol 2006; 124: 529-535. [Abstract] [Full text] [PDF]  

Epidemiology
Cognitive Impairment in the Age-Related Eye Disease Study: AREDS Report No. 16

Age-Related Eye Disease Study Research Group
Arch Ophthalmol 2006; 124: 537-543. [Abstract] [Full text] [PDF]  

Controversies
Perspectives on Verteporfin Therapy Combined With Intravitreal Corticosteroids

Ursula Schmidt-Erfurth; Stephan Michels; Albert Augustin
Arch Ophthalmol 2006; 124: 561-563. [Extract] [Full text] [PDF]  

Controversies
Should Corticosteroids Be Considered as Part of the Standard Care With Photodynamic Therapy?

Marco Zarbin
Arch Ophthalmol 2006; 124: 563-571. [Extract] [Full text] [PDF]  

Editorials
Complement Factor H and Macular Degeneration: The Genome Yields an Important Clue

Janey L. Wiggs
Arch Ophthalmol 2006; 124: 577-578. [Extract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30